White Marvin L 4
4 · Aptevo Therapeutics Inc. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
White Marvin L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-01-28+4,792→ 44,929 total - Exercise/Conversion
Restricted Stock Unit
2024-01-28−4,792→ 0 total→ Common Stock (4,792 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On January 29, 2021, the reporting person was granted 14,375 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.